CJC-1295 + Ipamorelin 10mg Per Vial

What is CJC-1295 + Ipamorelin?

CJC-1295 + Ipamorelin combines two research peptides that interact with different components of the growth-hormone signalling system. CJC-1295 is a synthetic analogue related to growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue receptor (GHS-R) agonist. Together, they provide researchers with an interesting model for studying complementary pathways involved in growth-hormone release.

CJC-1295 & Growth Hormone Research

CJC-1295 has been investigated for its ability to influence growth-hormone secretion through the GHRH pathway. Research has particularly focused on its interaction with the pituitary growth-hormone axis and the resulting changes in circulating growth hormone and IGF-1.

What is Ipamorelin?

Ipamorelin is a synthetic peptide that acts primarily through the growth hormone secretagogue receptor, also known as the ghrelin receptor. Unlike some older growth-hormone secretagogues, Ipamorelin has been studied for its relatively selective activity toward growth-hormone release.

Why combine the two?

The growth-hormone axis involves multiple signalling mechanisms. GHRH and ghrelin-related signalling are separate pathways that can both influence pituitary growth-hormone secretion. Studying CJC-1295 and Ipamorelin together therefore provides researchers with an opportunity to examine the interaction between these complementary pathways.

Growth Hormone & IGF-1 Research

Growth hormone stimulates downstream production of insulin-like growth factor-1 (IGF-1), which participates in numerous physiological processes involving growth, metabolism and tissue biology. Researchers can therefore study this combination within broader investigations into:

• Growth-hormone signalling
• Pituitary function
• IGF-1 pathways
• Metabolic signalling
• Cellular growth
• Endocrine biology

What makes this combination interesting?

• Two complementary pathways — Investigates GHRH-related and growth-hormone-secretagogue signalling.
  
  
• Endocrine research — Provides a model for studying the pituitary growth-hormone axis.
  
  
• IGF-1 research — Allows investigation of downstream growth-hormone signalling.
  
  
• Peptide research — Combines two distinct investigational peptide mechanisms.

Research Areas at a Glance

Growth Hormone • GHRH Signalling • GHS-R Signalling • IGF-1 • Pituitary Biology • Endocrine Research • Metabolic Signalling

Research Disclaimer: CJC-1295 and Ipamorelin are investigational research compounds and are not currently approved by SAHPRA, the FDA, or other major regulatory authorities as a combined therapeutic or consumer product. Peptigen products are provided exclusively for laboratory research. Information on this website is presented for general scientific and educational purposes and should not be considered medical advice, a treatment recommendation, or guidance for personal use. Peptigen does not provide dosing, administration or reconstitution guidance for research compounds. Purchasers are responsible for ensuring that research materials are handled within an appropriate research environment and in accordance with relevant laws, regulations, laboratory protocols and safety requirements. Research use only.

Peptigen.
Quality. Research. Potential.